Skip to main content
NCBI home page
Thorax logoLink to Thorax
editorial
. 1993 Aug;48(8):781–784. doi: 10.1136/thx.48.8.781

Chronic respiratory failure in COPD: is there a place for a respiratory stimulant?

P A Bardsley
PMCID: PMC464700  PMID: 8211866

Full text

PDF
781

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addis G. J. Theophylline in the management of airflow obstruction. 1. Much evidence suggests that theophylline is valuable. BMJ. 1990 Apr 7;300(6729):928–929. doi: 10.1136/bmj.300.6729.928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aubier M., Murciano D., Fournier M., Milic-Emili J., Pariente R., Derenne J. P. Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1980 Aug;122(2):191–199. doi: 10.1164/arrd.1980.122.2.191. [DOI] [PubMed] [Google Scholar]
  3. Bardsley P. A., Howard P., DeBacker W., Vermeire P., Mairesse M., Ledent C., Radermecker M., Bury T., Ansquer J. Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease. Eur Respir J. 1991 Mar;4(3):308–310. [PubMed] [Google Scholar]
  4. Bardsley P. A., Howard P., Tang O., Empey D., Harrison B., Peake M. D., O'Reilly J., Riordan J. F., Wilkinson J., Arnaud F. Sequential treatment with low dose almitrine bismesylate in hypoxaemic chronic obstructive airways disease. Eur Respir J. 1992 Oct;5(9):1054–1061. [PubMed] [Google Scholar]
  5. Bonora M., St John W. M., Bledsoe T. A. Differential elevation by protriptyline and depression by diazepam of upper airway respiratory motor activity. Am Rev Respir Dis. 1985 Jan;131(1):41–45. doi: 10.1164/arrd.1985.131.1.41. [DOI] [PubMed] [Google Scholar]
  6. Carroll N., Parker R. A., Branthwaite M. A. The use of protriptyline for respiratory failure in patients with chronic airflow limitation. Eur Respir J. 1990 Jul;3(7):746–751. [PubMed] [Google Scholar]
  7. Cochrane G. M. Slow release theophyllines and chronic bronchitis. Br Med J (Clin Res Ed) 1984 Dec 15;289(6459):1643–1644. doi: 10.1136/bmj.289.6459.1643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Connaughton J. J., Douglas N. J., Morgan A. D., Shapiro C. M., Critchley J. A., Pauly N., Flenley D. C. Almitrine improves oxygenation when both awake and asleep in patients with hypoxia and carbon dioxide retention caused by chronic bronchitis and emphysema. Am Rev Respir Dis. 1985 Aug;132(2):206–210. doi: 10.1164/arrd.1985.132.2.206. [DOI] [PubMed] [Google Scholar]
  9. Conway W. A., Zorick F., Piccione P., Roth T. Protriptyline in the treatment of sleep apnoea. Thorax. 1982 Jan;37(1):49–53. doi: 10.1136/thx.37.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cooper C. B., Waterhouse J., Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax. 1987 Feb;42(2):105–110. doi: 10.1136/thx.42.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DORRIS R., OLIVIA J. V., RODMAN T. DICHLORPHENAMIDE, A POTENT CARBONIC ANHYDRASE INHIBITOR. EFFECT ON ALVEOLAR VENTILATION, VENTILATION-PERFUSION RELATIONSHIPS AND DIFFUSION IN PATIENTS WITH CHRONIC LUNG DISEASE. Am J Med. 1964 Jan;36:79–86. doi: 10.1016/0002-9343(64)90150-0. [DOI] [PubMed] [Google Scholar]
  12. Daskalopoulou E., Patakas D., Tsara V., Zoglopitis F., Maniki E. Comparison of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep in patients with chronic obstructive lung disease. Thorax. 1990 Sep;45(9):666–669. doi: 10.1136/thx.45.9.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Delaunois L., Delwiche J. P., Lulling J. Effect of medroxyprogesterone on ventilatory control and pulmonary gas exchange in chronic obstructive patients. Respiration. 1985;47(2):107–113. doi: 10.1159/000194756. [DOI] [PubMed] [Google Scholar]
  14. Dolly F. R., Block A. J. Medroxyprogesterone acetate and COPD. Effect on breathing and oxygenation in sleeping and awake patients. Chest. 1983 Oct;84(4):394–398. doi: 10.1378/chest.84.4.394. [DOI] [PubMed] [Google Scholar]
  15. Douglas N. J., Flenley D. C. Breathing during sleep in patients with obstructive lung disease. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):1055–1070. doi: 10.1164/ajrccm/141.4_Pt_1.1055. [DOI] [PubMed] [Google Scholar]
  16. Dowell A. R., Heyman A., Sieker H. O., Tripathy K. Effect of aminophylline on respiratory-center sensitivity in Cheynestokes respiration and in pulmonary emphysema. N Engl J Med. 1965 Dec 30;273(27):1447–1453. doi: 10.1056/NEJM196512302732702. [DOI] [PubMed] [Google Scholar]
  17. Ebden P., Vathenen A. S. Does aminophylline improve nocturnal hypoxia in patients with chronic airflow obstruction? Eur J Respir Dis. 1987 Nov;71(5):384–387. [PubMed] [Google Scholar]
  18. Evans T. W., Tweney J., Waterhouse J. C., Nichol J., Suggett A. J., Howard P. Almitrine bismesylate and oxygen therapy in hypoxic cor pulmonale. Thorax. 1990 Jan;45(1):16–21. doi: 10.1136/thx.45.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fencl V., Vale J. R., Broch J. A. Respiration and cerebral blood flow in metabolic acidosis and alkalosis in humans. J Appl Physiol. 1969 Jul;27(1):67–76. doi: 10.1152/jappl.1969.27.1.67. [DOI] [PubMed] [Google Scholar]
  20. GALDSTON M. Respiratory and renal effects of a carbonic anhydrase inhibitor (diamox) on acid-base balance in normal man and in patients with respiratory acidosis. Am J Med. 1955 Oct;19(4):516–532. doi: 10.1016/0002-9343(55)90344-2. [DOI] [PubMed] [Google Scholar]
  21. Gothe B., Cherniack N. S., Bachand R. T., Jr, Szalkowski M. B., Bianco K. A. Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease. Am J Med. 1988 Mar;84(3 Pt 1):436–444. doi: 10.1016/0002-9343(88)90263-x. [DOI] [PubMed] [Google Scholar]
  22. Hill N. S. The use of theophylline in 'irreversible' chronic obstructive pulmonary disease. An update. Arch Intern Med. 1988 Dec;148(12):2579–2584. [PubMed] [Google Scholar]
  23. Javaheri S., Guerra L. Lung function, hypoxic and hypercapnic ventilatory responses, and respiratory muscle strength in normal subjects taking oral theophylline. Thorax. 1990 Oct;45(10):743–747. doi: 10.1136/thx.45.10.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Johnston I. D. Theophylline in the management of airflow obstruction. 2. Difficult drugs to use, few clinical indications. BMJ. 1990 Apr 7;300(6729):929–931. doi: 10.1136/bmj.300.6729.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lakshminarayan S., Sahn S. A., Weil J. V. Effect of aminophylline on ventilatory responses in normal man. Am Rev Respir Dis. 1978 Jan;117(1):33–38. doi: 10.1164/arrd.1978.117.1.33. [DOI] [PubMed] [Google Scholar]
  26. Le Merre C., Ansquer J. C., Clark M. J., Zouari N., Préfaut C. Is the mode of action of almitrine bismesylate dose dependent? Respiration. 1989;56(3-4):212–219. doi: 10.1159/000195803. [DOI] [PubMed] [Google Scholar]
  27. MacNee W., Connaughton J. J., Rhind G. B., Hayhurst M. D., Douglas N. J., Muir A. L., Flenley D. C. A comparison of the effects of almitrine or oxygen breathing on pulmonary arterial pressure and right ventricular ejection fraction in hypoxic chronic bronchitis and emphysema. Am Rev Respir Dis. 1986 Sep;134(3):559–565. doi: 10.1164/arrd.1986.134.3.559. [DOI] [PubMed] [Google Scholar]
  28. Martin R. J., Pak J. Overnight theophylline concentrations and effects on sleep and lung function in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992 Mar;145(3):540–544. doi: 10.1164/ajrccm/145.3.540. [DOI] [PubMed] [Google Scholar]
  29. Millman R. P. Medroxyprogesterone and obstructive sleep apnea. Chest. 1989 Aug;96(2):225–226. doi: 10.1378/chest.96.2.225. [DOI] [PubMed] [Google Scholar]
  30. Mélot C., Naeije R., Rothschild T., Mertens P., Mols P., Hallemans R. Improvement in ventilation-perfusion matching by almitrine in COPD. Chest. 1983 Mar;83(3):528–533. doi: 10.1378/chest.83.3.528. [DOI] [PubMed] [Google Scholar]
  31. Naeije R., Mélot C., Mols P., Hallemans R., Naeije N., Cornil A., Sergysels R. Effects of almitrine in decompensated chronic respiratory insufficiency. Bull Eur Physiopathol Respir. 1981;17(2):153–161. [PubMed] [Google Scholar]
  32. Powles A. C., Tuxen D. V., Mahood C. B., Pugsley S. O., Campbell E. J. The effect of intravenously administered almitrine, a peripheral chemoreceptor agonist, on patients with chronic air-flow obstruction. Am Rev Respir Dis. 1983 Mar;127(3):284–289. doi: 10.1164/arrd.1983.127.3.284. [DOI] [PubMed] [Google Scholar]
  33. Räsänen J. Respiratory support in patients with heart failure. Bull Eur Physiopathol Respir. 1987 Mar-Apr;23(2):183–195. doi: 10.1007/978-3-642-83010-5_17. [DOI] [PubMed] [Google Scholar]
  34. Rühle K. H., Kempf P., Mössinger B., Klein G., Costabel U., Würtemberger G., Matthys H. Einfluss von Almitrin, einem Chemorezeptorenstimulator, auf die nächtliche Hyperkapnie und den pulmonalarteriellen Druck unter O2-Atmung bei chronisch obstruktiver Lungenerkrankung. Prax Klin Pneumol. 1988 Jun;42 (Suppl 1):411–414. [PubMed] [Google Scholar]
  35. Sanders J. S., Berman T. M., Bartlett M. M., Kronenberg R. S. Increased hypoxic ventilatory drive due to administration of aminophylline in normal men. Chest. 1980 Aug;78(2):279–282. doi: 10.1378/chest.78.2.279. [DOI] [PubMed] [Google Scholar]
  36. Simonds A. K., Carroll N., Branthwaite M. A., Saunders N. A. Effect of protriptyline on ventilatory responses to hypercapnia and asphyxia in normal subjects. Eur Respir J. 1989 Sep;2(8):758–762. [PubMed] [Google Scholar]
  37. Skatrud J. B., Dempsey J. A., Bhansali P., Irvin C. Determinants of chronic carbon dioxide retention and its correction in humans. J Clin Invest. 1980 Apr;65(4):813–821. doi: 10.1172/JCI109732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Skatrud J. B., Dempsey J. A., Iber C., Berssenbrugge A. Correction of CO2 retention during sleep in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis. 1981 Sep;124(3):260–268. doi: 10.1164/arrd.1981.124.3.260. [DOI] [PubMed] [Google Scholar]
  39. Skatrud J. B., Dempsey J. A. Relative effectiveness of acetazolamide versus medroxyprogesterone acetate in correction of chronic carbon dioxide retention. Am Rev Respir Dis. 1983 Apr;127(4):405–412. doi: 10.1164/arrd.1983.127.4.405. [DOI] [PubMed] [Google Scholar]
  40. Sorli J., Grassino A., Lorange G., Milic-Emili J. Control of breathing in patients with chronic obstructive lung disease. Clin Sci Mol Med. 1978 Mar;54(3):295–304. doi: 10.1042/cs0540295. [DOI] [PubMed] [Google Scholar]
  41. Stradling J. R., Nicholl C. G., Cover D., Davies E. E., Hughes J. M., Pride N. B. The effects of oral almitrine on pattern of breathing and gas exchange in patients with chronic obstructive pulmonary disease. Clin Sci (Lond) 1984 Apr;66(4):435–442. doi: 10.1042/cs0660435. [DOI] [PubMed] [Google Scholar]
  42. Swaminathan S., Paton J. Y., Ward S. L., Sargent C. W., Keens T. G. Theophylline does not increase ventilatory responses to hypercapnia or hypoxia. Am Rev Respir Dis. 1992 Dec;146(6):1398–1401. doi: 10.1164/ajrccm/146.6.1398. [DOI] [PubMed] [Google Scholar]
  43. Sériès F., Cormier Y. Effects of protriptyline on diurnal and nocturnal oxygenation in patients with chronic obstructive pulmonary disease. Ann Intern Med. 1990 Oct 1;113(7):507–511. doi: 10.7326/0003-4819-113-7-507. [DOI] [PubMed] [Google Scholar]
  44. Weitzenblum E., Schrijen F., Apprill M., Prefaut C., Yernault J. C. One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients. Eur Respir J. 1991 Nov;4(10):1215–1222. [PubMed] [Google Scholar]
  45. Zwillich C. W., Natalino M. R., Sutton F. D., Weil J. V. Effects of progesterone on chemosensitivity in normal men. J Lab Clin Med. 1978 Aug;92(2):262–269. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES